Wells Fargo
DRUG

Wells Fargo’s Bright Minds Biosciences DRUG Stock Holding History

Wells Fargo’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Buy
6,761
+4,229
+167% +$332K ﹤0.01% 4668
2026
Q1 		$185K Sell
2,532
-2,991
-54% -$241K ﹤0.01% 4748
2025
Q4 		$431K Buy
5,523
+2,697
+95% +$180K ﹤0.01% 4600
2025
Q3 		$171K Buy
2,826
+448
+19% +$17.4K ﹤0.01% 5011
2025
Q2 		$62.1K Buy
+2,378
New +$71.3K ﹤0.01% 5436

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wells Fargo's DRUG Position: Q2 2026 in Review

Wells Fargo increased its Bright Minds Biosciences (DRUG) stake by 167% in Q2 2026, buying an estimated $332K and bringing the position to 6,761 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #4668.

Wells Fargo first reported a position in DRUG in Q2 2025 and has held it in 5 quarters since. 99 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Wells Fargo held 6,761 shares of Bright Minds Biosciences worth $475K as of Q2 2026.
  • Wells Fargo bought 4,229 Bright Minds Biosciences shares in Q2 2026, an estimated $332K.
  • Bright Minds Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4668 holding.
  • Wells Fargo first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 99 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.